• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging.

作者信息

Gilardi Laura, Grana Chiara Maria, Paganelli Giovanni

机构信息

Division of Nuclear Medicine, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy,

出版信息

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2090-2. doi: 10.1007/s00259-014-2848-x. Epub 2014 Jul 11.

DOI:10.1007/s00259-014-2848-x
PMID:25012872
Abstract
摘要

相似文献

1
Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging.免疫治疗反应的评估：PET成像面临的新挑战与机遇
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2090-2. doi: 10.1007/s00259-014-2848-x. Epub 2014 Jul 11.
2
The role of PET in imaging of the tumour microenvironment and response to immunotherapy.PET 在肿瘤微环境成像及免疫治疗反应评估中的作用。
Clin Radiol. 2021 Oct;76(10):784.e1-784.e15. doi: 10.1016/j.crad.2021.08.004.
3
PET imaging for cancer immunotherapy: the Immuno-PET.
Ann Oncol. 2022 Jan;33(1):13-14. doi: 10.1016/j.annonc.2021.11.003. Epub 2021 Nov 19.
4
Update on tumor metabolism and patterns of response to immunotherapy.肿瘤代谢与免疫治疗应答模式的最新进展。
Q J Nucl Med Mol Imaging. 2020 Jun;64(2):175-185. doi: 10.23736/S1824-4785.20.03251-3. Epub 2020 Feb 27.
5
PET imaging of cancer immunotherapy.癌症免疫治疗的正电子发射断层显像（PET）成像
J Nucl Med. 2008 Jun;49(6):865-8. doi: 10.2967/jnumed.108.051342.
6
Programmed Cell Death-1/Ligand-1 PET Imaging: A Novel Tool to Optimize Immunotherapy?程序性细胞死亡蛋白-1/配体-1正电子发射断层显像：优化免疫治疗的新型工具？
PET Clin. 2020 Jan;15(1):35-43. doi: 10.1016/j.cpet.2019.08.008. Epub 2019 Oct 29.
7
Molecular Imaging for Cancer Immunotherapy: Seeing Is Believing.癌症免疫治疗的分子影像学：眼见为实。
Bioconjug Chem. 2020 Feb 19;31(2):404-415. doi: 10.1021/acs.bioconjchem.9b00851. Epub 2020 Jan 27.
8
Outcome Prediction and Evaluation by Imaging the Key Elements of Therapeutic Responses to Cancer Immunotherapies Using PET.使用 PET 对癌症免疫治疗的关键反应因素进行成像以进行预后预测和评估。
Curr Pharm Des. 2020;26(6):675-687. doi: 10.2174/1381612825666190829150302.
9
The chemical tool-kit for molecular imaging with radionuclides in the age of targeted and immune therapy.放射性核素分子成像的化学工具包——在靶向和免疫治疗时代。
Cancer Imaging. 2021 Jan 30;21(1):18. doi: 10.1186/s40644-021-00385-8.
10
[Use of PET for evaluation of treatment response in oncology].
Cancer Radiother. 2006 Nov;10(6-7):334-7. doi: 10.1016/j.canrad.2006.07.013. Epub 2006 Sep 6.

引用本文的文献

1
Predictive value and accuracy of [F]FDG PET/CT modified response criteria for checkpoint immunotherapy in patients with advanced melanoma.[F]FDG PET/CT 改良的反应标准对晚期黑色素瘤患者检查点免疫治疗的预测价值和准确性。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2715-2726. doi: 10.1007/s00259-023-06247-8. Epub 2023 May 4.
2
Neoadjuvant immunotherapy in resectable head and neck cancer: oral cavity carcinoma as a potential research model.可切除头颈癌的新辅助免疫治疗：口腔癌作为潜在的研究模型
Ther Adv Med Oncol. 2021 Feb 23;13:1758835920984061. doi: 10.1177/1758835920984061. eCollection 2021.
3
Thyroid cancer diagnosis in the era of precision imaging.

本文引用的文献

1
(123)I-BZA2 as a melanin-targeted radiotracer for the identification of melanoma metastases: results and perspectives of a multicenter phase III clinical trial.(123)I-BZA2 作为一种黑色素靶向放射性示踪剂，用于识别黑色素瘤转移：一项多中心 III 期临床试验的结果和展望。
J Nucl Med. 2014 Jan;55(1):15-22. doi: 10.2967/jnumed.113.123554. Epub 2013 Nov 21.
2
A novel aliphatic 18F-labeled probe for PET imaging of melanoma.一种用于黑色素瘤正电子发射断层显像（PET）成像的新型脂肪族18F标记探针。
Mol Pharm. 2013 Sep 3;10(9):3384-91. doi: 10.1021/mp400225s. Epub 2013 Aug 22.
3
Ipilimumab-induced immunomediated adverse events: possible pitfalls in (18)F-FDG PET/CT interpretation.
精准成像时代的甲状腺癌诊断
J Thorac Dis. 2020 Sep;12(9):5128-5139. doi: 10.21037/jtd.2019.08.37.
4
Positron Emission Tomography in Merkel Cell Carcinoma.正电子发射断层扫描在默克尔细胞癌中的应用
Cancers (Basel). 2020 Oct 9;12(10):2897. doi: 10.3390/cancers12102897.
5
The value of F-FDG PET/CT for predicting or monitoring immunotherapy response in patients with metastatic melanoma: a systematic review and meta-analysis.F-FDG PET/CT 预测或监测转移性黑色素瘤患者免疫治疗反应的价值：系统评价和荟萃分析。
Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):428-448. doi: 10.1007/s00259-020-04967-9. Epub 2020 Jul 29.
6
Evaluation of Diffusion-Weighted MRI and FDG-PET/CT to Assess Response to AdCD40L treatment in Metastatic Melanoma Patients.评估扩散加权 MRI 和 FDG-PET/CT 以评估转移性黑色素瘤患者对 AdCD40L 治疗的反应。
Sci Rep. 2019 Dec 2;9(1):18069. doi: 10.1038/s41598-019-54438-x.
7
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-A Review From the Melanoma Perspective and Beyond.免疫检查点抑制剂治疗临床获益的生物标志物——从黑色素瘤及其他角度的综述
Front Immunol. 2018 Jun 28;9:1474. doi: 10.3389/fimmu.2018.01474. eCollection 2018.
8
Longitudinal studies of the F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT.基于 FDG PET/CT 动态显像的转移性黑色素瘤患者接受伊匹单抗治疗后的 F-FDG 动力学纵向研究。
Cancer Immunol Immunother. 2018 Aug;67(8):1261-1270. doi: 10.1007/s00262-018-2183-3. Epub 2018 Jun 5.
9
The role of interim F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma.中期 F-FDG PET/CT 在预测转移性黑色素瘤对伊匹单抗治疗反应中的作用。
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1289-1296. doi: 10.1007/s00259-018-3972-9. Epub 2018 Feb 24.
依匹单抗所致免疫介导不良反应：(18)F-FDG PET/CT 解读中的潜在陷阱。
Clin Nucl Med. 2014 May;39(5):472-4. doi: 10.1097/RLU.0b013e31828da691.
4
Immune toxicities and long remission duration after ipilimumab therapy for metastatic melanoma: two illustrative cases.免疫毒性和伊匹单抗治疗转移性黑色素瘤后的长期缓解持续时间：两例说明性病例。
Curr Oncol. 2013 Apr;20(2):e165-9. doi: 10.3747/co.20.1265.
5
Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma.依匹单抗治疗相关特殊关注免疫相关不良事件的发生和解决模式：晚期黑色素瘤患者 3 期试验的详细安全性分析。
Cancer. 2013 May 1;119(9):1675-82. doi: 10.1002/cncr.27969. Epub 2013 Feb 7.
6
Ipilimumab in combination with paclitaxel and carboplatin as first-line therapy in extensive-disease-small-cell lung cancer: results from a randomized, double-blind, multicenter phase 2 trial.伊匹单抗联合紫杉醇和卡铂作为广泛期小细胞肺癌的一线治疗：一项随机、双盲、多中心 2 期临床试验的结果。
Ann Oncol. 2013 Jan;24(1):75-83. doi: 10.1093/annonc/mds213. Epub 2012 Aug 2.
7
Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging.新型 68Ga 标记 DOTA-苯甲酰胺衍生物的合成与评价用于恶性黑色素瘤成像。
Bioorg Med Chem Lett. 2012 Aug 15;22(16):5288-92. doi: 10.1016/j.bmcl.2012.06.043. Epub 2012 Jun 19.
8
Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.使用[¹⁰F]ICF01006 对实验性原发性和播散性黑色素瘤进行早期检测和纵向监测，这是一种很有前途的黑色素瘤 PET 示踪剂。
Eur J Nucl Med Mol Imaging. 2012 Sep;39(9):1449-61. doi: 10.1007/s00259-012-2168-y. Epub 2012 Jun 16.
9
Immunotherapy of cancer in 2012.2012 年的癌症免疫疗法。
CA Cancer J Clin. 2012 Sep-Oct;62(5):309-35. doi: 10.3322/caac.20132. Epub 2012 May 10.
10
Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.伊匹单抗联合紫杉醇和卡铂作为 IIIB/IV 期非小细胞肺癌一线治疗：一项随机、双盲、多中心 II 期研究的结果。
J Clin Oncol. 2012 Jun 10;30(17):2046-54. doi: 10.1200/JCO.2011.38.4032. Epub 2012 Apr 30.